Prognostic Utility of GDF-15 in Chronic Heart Failure: Insights From the HF-ACTION Study
28 August 2016 (16:30 - 16:39)
Organised by:
About the speaker

Duke Clinical Research Institute, Durham (United States of America)
9 More presentations in this session

Mr A. Salgado Somoza (Luxembourg, LU)

Doctor C. Sinning (Hamburg, DE)

Doctor B. Demissei (Groningen, NL)

Doctor A. Bayes Genis (Badalona, ES)
Access the full session
The Event
ESC Congress 2016
28 August 2016
16:30 CET

